Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × tisagenlecleucel × Lymphoid × Clear all

Phase

Status

Completed 12 Recruiting 5 Active not recruiting 5 Withdrawn 4 Terminated 2 Suspended 1 Not yet recruiting 1 Available 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, B-Cell 1

Interventions

Cyclophosphamide 21 zanubrutinib 19 Rituximab 19 blinatumomab 14 venetoclax 11 obinutuzumab 11 Vincristine 10 Bendamustine Hydrochloride 10 fludarabine 9 Specimen Handling 9 Magnetic Resonance Spectroscopy 9 Lenalidomide 9 Prednisone 8 glofitamab 7 Immunotherapy, Adoptive 7 Doxorubicin 7 Biopsy 6 polatuzumab vedotin 5 Methotrexate 5 Cytarabine 5 orelabrutinib 4 Prednisolone 4 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 4 Gemcitabine 4 Dexamethasone 4 Azacitidine 4 tislelizumab 3 ruxolitinib 3 pegaspargase 3 fludarabine phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04419909 2025-07-02

Retreatment With CTL019/CTL119

University of Pennsylvania

Phase 1 Not yet recruiting

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡